NSE · Healthcare · Medical Instruments & Supplies
EPS came in at 8.48 against a street estimate of 7.08 — a beat of 19.8%.
with an average price target of ₹1,858.17.
| Holder | Stake |
|---|---|
| Quant Mutual Fund - Qsif Hybrid Long-short Fund | 4.61% |
| Lighthouse India Fund IV AIF | 2.33% |
| Axis Max Life Insurance Limited A/C Uegfh - High Growth Fund II | 2.14% |
| Uti-unit Linked Insurance Plan | 1.52% |
| SBI Nifty Smallcap 250 ETF | 1.22% |
| Document | Date |
|---|---|
| Annual report FY2026 | 2026-08-14 |
| Q1 FY27 earnings call POLY MEDICURE LIMITED – Q1 FY27 SUMMARY HEADLINE NUMBERS • Stand-alone revenue Q1 FY27: INR 431 crores, up 12.3% YoY - Domestic: INR 146 crores, u | 2026-08-14 |
| Investor presentation · Q1 FY27 POLY MEDICURE LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Q1 FY27 Consolidated Revenue: Rs 525.4 Cr (30.3% YoY growth); Standalone Revenue: Rs 431 | 2026-08-07 |
| Quarterly results · Q1 FY27 POLY MEDICURE LIMITED - INVESTOR SUMMARY HEADLINE NUMBERS • Q1 FY2027 Standalone Revenue from Operations: Rs 43,109.95 lacs (down 2.7% YoY from Rs 3 | 2026-08-07 |
| Q4 FY26 earnings call POLY MEDICURE LIMITED – Q4 FY26 SUMMARY HEADLINE NUMBERS • Full year FY26 standalone revenue: INR 1,662 crores, up 4% YoY • Full year FY26 consolida | 2026-05-29 |
| Quarterly results · Q4 FY26 POLY MEDICURE LIMITED – FINANCIAL SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Revenue from Operations (FY 2025-26 Standalone): ₹4,69,565.18 lacs | 2026-05-25 |
| Investor presentation · Q4 FY26 POLY MEDICURE LIMITED – INVESTOR SUMMARY Q4 & FY26 RESULTS --- HEADLINE NUMBERS • FY26 Standalone Revenue: Rs 1,662.5 Cr (+3.8% YoY); Q4 FY26: Rs 4 | 2026-05-25 |
| Investor presentation | 2026-05-25 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹3.50 / share ex-date Aug 28, 2026 · record Aug 29, 2026 | 2026-08-28 |
| Dividend | ₹3.50 / share ex-date Sep 18, 2025 | 2025-09-18 |
| Announcement | Date |
|---|---|
| Acquisition of subsidiary company completed Poly Medicure Limited, a medical device manufacturer, has announced the acquisition of a subsidiary company as per regulatory disclosure requirements under SEBI guidelines. Key Details: - T | 2026-04-30 |
| Completion of acquisition of Medistream SA by subsidiary Poly Medicure Limited has completed its acquisition of Medistream SA, a Swiss corporation, through its wholly-owned subsidiary Poly Medicure B.V. based in Amsterdam, Netherlands. Key Points | 2025-11-06 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Poly Medicure Limited — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.